Comparative genotyping and phenotyping of Aspergillus fumigatus isolates from humans, dogs and the environment
Authors:
- Ivan D. ValdesIVIvan D. Valdes
- Joris van Den BergJBJoris van Den Berg
- Annika HaagsmanAHAnnika Haagsman
- Natalia EscobarNENatalia Escobar
- Jacques F. MeisJMJacques F. Meis
- Ferry HagenFHFerry Hagen
- Pieter Jan HaasPHPieter Jan Haas
- Jos HoubrakenJHJos Houbraken
- Han A. B. WöstenHan A. B. Wösten
- Hans de CockHans de Cock
Open Access
- 17 September 2018
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 18 (1) , 1-11
Abstract
Aspergillus fumigatus is a ubiquitous saprotrophic fungus and an opportunistic pathogen of humans and animals. Humans and animals can inhale hundreds of A. fumigatus spores daily. Normally this is harmless for humans, but in case of immunodeficiency, invasive pulmonary aspergillosis (IPA) can develop with a high mortality rate. A. fumigatus also causes non-invasive mycoses like sino-nasal aspergillosis (SNA) in dogs. In this study we compared A. fumigatus isolates from humans with suspected IPA, dogs with SNA, and a set of environmental isolates. Phylogenetic inference based on calmodulin (CaM) and beta-tubulin (benA) sequences did not reveal A. fumigatus sub-groups linked to the origin of the isolates. Genotyping and microsatellite analysis showed that each dog was infected by one A. fumigatus genotype, whereas human patients had mixed infections. Azole resistance was determined by antifungal susceptibility testing and sequencing of the cyp51A gene. A total of 12 out of 29 human isolates and 1 out of 27 environmental isolates were azole resistant. Of the azole resistant strains, 11 human isolates showed TR34/L98H (n = 6) or TR46/Y121F/T289A (n = 5). Phenotypically, isolates from dogs were more variable in growth speed and morphology when compared to those isolated from human and the environment.Keywords
This publication has 56 references indexed in Scilit:
- Aspergillus felis sp. nov., an Emerging Agent of Invasive Aspergillosis in Humans, Cats, and DogsPLOS ONE, 2013
- Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatusMolecular Ecology, 2011
- Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infectionBritish Journal of Haematology, 2010
- Innate Immunity toAspergillusSpeciesClinical Microbiology Reviews, 2009
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance MechanismPLOS Medicine, 2008
- Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilmsJournal of Antimicrobial Chemotherapy, 2008
- Genomic Islands in the Pathogenic Filamentous Fungus Aspergillus fumigatusPLOS Genetics, 2008
- A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A AlterationsAntimicrobial Agents and Chemotherapy, 2007
- Comparison of Two Highly Discriminatory Molecular Fingerprinting Assays for Analysis of Multiple Aspergillus fumigatus Isolates from Patients with Invasive AspergillosisJournal of Clinical Microbiology, 2007
- Use of a Novel Panel of Nine Short Tandem Repeats for Exact and High-Resolution Fingerprinting of Aspergillus fumigatus IsolatesJournal of Clinical Microbiology, 2005